Avoiding Missteps During the Chain of Title Review: Understanding Ownership Rules

November 14, 2019 10:45am

Jeffrey N. Myers
Vice President & Assistant General Counsel
Pfizer Inc. (New York, NY)

Adam Strauss
Chief Intellectual Property Counsel
Stryker (Kalamazoo, MI)

Marina Volin
VP, Head of Legal and IP
Kintai Therapeutics, Inc. (Cambridge, MA)

Jen Sieczkiewicz Zarutskie
VP, Chief Intellectual Property Counsel
Wave Life Sciences (Cambridge, MA)

Moderator:

David J. Dykeman
Shareholder
Greenberg Traurig, LLP (Boston, MA)

Before you can consider the value of proprietary technology, you must first determine and identify who has clear title or a fully protectable interest. This session will answer your most unyielding questions concerning ownership, including:
  • Who is the true owner of the patents?
  • Have the patents been maintained in force and the patent applications in good standing?
  • Have any prior investors or creditors encumbered the IP by imposing liens?
  • Has there been a valid and inclusive assignment of patents to the licensor?